Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
365,569
-
Share change
-
+182,169
-
Total reported value
-
$817,067
-
Price per share
-
$2.24
-
Number of holders
-
15
-
Value change
-
+$418,875
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2017
As of 31 Dec 2017,
Aptose Biosciences Inc. - Common Shares was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
365,569 shares.
The largest 10 holders included
MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, BRANDES INVESTMENT PARTNERS, LP, DRW Securities, LLC, US BANCORP \DE\, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, JPMORGAN CHASE & CO, and ROYAL BANK OF CANADA.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.